Animalcare Group Company Description

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.

It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in horses; Dinalgen, an injectable treatment for pain in cattle, pigs, and horses; Aqupharm, a dehydration treatment for cats, dogs, cattle, goats, horses, pigs, rabbits, and sheep; Ulcershield, a treatment and prevention of gastric ulcers in horses; Daxocox, a treatment of osteoarthritis pain and inflammation in dogs; Plaqtiv+, a biofilm-based dental care for cats and dogs; Thiamacare, a treatment for hyperthyroidism in cats; Hemo, an injectable nutritional solution for horses; and Cosequin, a complementary feed for dogs and cats to strengthen and protect joints.

It also provides nutritional supplements for the equine market; and professional support services to equine veterinarians.

The company exports its products to approximately 45 countries. It has a collaboration with 272Bio to develop and commercialize a novel biological treatment for equine sweet itch.

Animalcare Group plc is based in York, the United Kingdom.

Animalcare Group plc

Country	United Kingdom
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	220
CEO	Jennifer Ann Winter

Contact Details

Address: Moorside York, YO32 9LB United Kingdom
Phone	44 1904 487 687
Website	animalcaregroup.com

Stock Details

Ticker Symbol	ANCR
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB0032350695
SIC Code	2834

Key Executives

Name	Position
Jennifer Ann Winter	Chief Executive Officer
Christopher Brewster	Chief Financial Officer